Chemoinformaics analysis of 2,4-DIMETHOXY-5-[(1S)-1-PHENYLPROP-2-ENYL]PHENOL
| Molecular Weight | 270.328 | nRot | 5 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 13 |
| Exact Molecular Weight | 270.126 | nRing | 2 |
| Solubility: LogS | -4.349 | nHRing | 0 |
| Solubility: LogP | 3.496 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 42.7983 |
| nHD | 1 | BPOL | 21.5297 |
| QED | 0.841 |
| Synth | 2.745 |
| Natural Product Likeliness | 1.042 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.187 |
| Pgp-sub | 0.013 |
| HIA | 0.005 |
| CACO-2 | -4.657 |
| MDCK | 0.0000191 |
| BBB | 0.078 |
| PPB | 0.984994 |
| VDSS | 0.708 |
| FU | 0.0108437 |
| CYP1A2-inh | 0.676 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.927 |
| CYP2c19-sub | 0.924 |
| CYP2c9-inh | 0.821 |
| CYP2c9-sub | 0.908 |
| CYP2d6-inh | 0.806 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.822 |
| CYP3a4-sub | 0.899 |
| CL | 8.268 |
| T12 | 0.461 |
| hERG | 0.04 |
| Ames | 0.046 |
| ROA | 0.125 |
| SkinSen | 0.094 |
| Carcinogencity | 0.205 |
| EI | 0.392 |
| Respiratory | 0.848 |
| NR-Aromatase | 0.152 |
| Antiviral | No |
| Prediction | 0.687827 |